Post-approval studies (Phase 4)UnknownNCT01501136What this trial is testingTreatment of Natural Killer/T Cell Lymphoma-I/IIWho this might be right forNasal and Nasal-type NK/T-cell Lymphoma Mingzhi Zhang 200
Not applicableStudy completedNCT00521430What this trial is testingDonor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Asan Medical Center 30
Not applicableStudy completedNCT00112593What this trial is testingFludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+176 more Fred Hutchinson Cancer Center 5
Not applicableWithdrawnNCT00499668What this trial is testingAprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With CancerWho this might be right forMyeloproliferative DisordersLeukemiaLymphoma+5 more Vanderbilt-Ingram Cancer Center
Testing effectiveness (Phase 2)UnknownNCT04338282What this trial is testingMaintenance Therapy With Anti-PD-1 Antibody for Patients With NK/T-cell LymphomaWho this might be right forExtranodal NK/T-cell Lymphoma, Nasal Type Beijing Tongren Hospital 20
Early research (Phase 1)Study completedNCT00963274What this trial is testingBortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaWho this might be right forLeukemiaLymphoma Virginia Commonwealth University 18
Testing effectiveness (Phase 2)WithdrawnNCT03999658What this trial is testingSTI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory MalignanciesWho this might be right forPeripheral T Cell LymphomaDiffuse Large B Cell LymphomaBiliary Tract Cancer+1 more Sorrento Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT03228836What this trial is testingEfficacy and Safety Evaluation of IBI308 in Patients With Extranodal NK/T Cell Lymphoma PatientsWho this might be right forEffect of Drugs Innovent Biologics (Suzhou) Co. Ltd. 28
Not applicableLooking for participantsNCT06069830What this trial is testingPET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell LymphomaWho this might be right forNK-T-Cell Lymphoma, Extranodal Ruijin Hospital 89
Early research (Phase 1)Study completedNCT01158274What this trial is testingRO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell Lymphoma+83 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00089011What this trial is testingTacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+171 more Fred Hutchinson Cancer Center 150
Not applicableWithdrawnNCT01769911What this trial is testingGenetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell Lymphoma+42 more Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT01643603What this trial is testingDasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic MalignanciesWho this might be right forNon-Hodgkin's LymphomaHodgkin's LymphomaMyeloid Leukemia+3 more Barbara Ann Karmanos Cancer Institute 5
Testing effectiveness (Phase 2)UnknownNCT02560441What this trial is testingTrial of IPGDP Regimen Chemotherapy in Patients With Extranodal Natural Killer/T-Cell Lymphoma, Nasal TypeWho this might be right forExtranodal Natural Killer/T-Cell Lymphoma, Nasal Type Chinese Academy of Medical Sciences
Testing effectiveness (Phase 2)Study completedNCT00787761What this trial is testingEarly Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological CancerWho this might be right forMyeloproliferative DisordersKidney CancerLeukemia+4 more Northside Hospital, Inc. 24
Large-scale testing (Phase 3)Study completedNCT00661999What this trial is testingDarbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With CancerWho this might be right forAnemiaLeukemiaLymphoma+4 more Mayo Clinic 502
Large-scale testing (Phase 3)Study completedNCT00666211What this trial is testingOpioid Titration Order Sheet or Standard Care in Treating Patients With Cancer PainWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more Vanderbilt-Ingram Cancer Center 98
Testing effectiveness (Phase 2)UnknownNCT00740467What this trial is testingStem Cell Transplant in Treating Patients With Hematological Cancer or Other DisordersWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Institut Paoli-Calmettes 50
Testing effectiveness (Phase 2)Study completedNCT01326702What this trial is testingVeliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid TumorsWho this might be right forAdult B Acute Lymphoblastic LeukemiaAdult Nasal Type Extranodal NK/T-Cell LymphomaAdult Solid Neoplasm+35 more National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Ended earlyNCT01419795What this trial is testingLenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell TransplantWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more Fred Hutchinson Cancer Center 3